Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study
Ashray Rajagopalan,Somaiah Aroori,Thomas B Russell,Peter L Labib,Fabio Ausania,Elizabeth Pando,Keith J Roberts,Ambareen Kausar,Vasileios K Mavroeidis,Gabriele Marangoni,Sarah C Thomasset,Adam E Frampton,Pavlos Lykoudis,Manuel Maglione,Nassir Alhaboob,Hassaan Bari,Andrew M Smith,Duncan Spalding,Parthi Srinivasan,Brian R Davidson,Ricky H Bhogal,Ismael Dominguez,Rohan Thakkar,Dhanny Gomez,Michael A Silva,Pierfrancesco Lapolla,Andrea Mingoli,Alberto Porcu,Nehal S Shah,Zaed Z R Hamady,Bilal Al-Sarrieh,Alejandro Serrablo,Daniel Croagh,RAW Study Collaborators,Lead Unit,Adam Streeter,Jemimah Denson,Mark Puckett,Shang-Ming Zhou,Matthew Browning,Collaborating Units,Carolina Gonzalez-Abos,Nair Fernandes,Elsa G Moller,Cristina D Taboada,Keith Roberts,Rupaly Pande,Jameel Alfarah,Samik Bandyopadhyay,Ahmed Abdelrahim,Ayesha Khan,Caitlin Jordan,Jonathan R E Rees,Harry Blege,Sarah Thomasset,William Cambridge,Olga White,Adam Frampton,Sarah Blacker,Jessie Blackburn,Casie Sweeney,Daniel Field,Mohammed Gouda,Ruben Bellotti,Hytham K S Hamid,Hassan Ahmed,Andrew Smith,Catherine Moriarty,Louise White,Mark Priestley,Kerry Bode,Judith Sharp,Rosie Wragg,Beverley Jackson,Samuel Craven,Matyas Fehervari,Madhava Pai,Laith Alghazawi,Anjola Onifade,Julliette Ribaud,Ashitha Nair,Michael Mariathasan,Niamh Grayson,Brian Davidson,Stephanos Pericleous,Krishna Patel,Conrad Shaw,Nolitha Morare,Mohamad K Zaban,Ricky Bhogal,Joseph Doyle,Alan Guerrero,Andre Moguel,Carlos Chan,Michael Jones,Edward Buckley,Nasreen Akter,Kyle Treherne,Gregory Gordon,Michael Silva,Daniel Hughes,Tomas Urbonas,Gioia Brachini,Roberto Caronna,Piero Chirletti,Teresa Perra,Nurul N Abd Kahar,Thomas Hall,Nabeegh Nadeem,Zaed Hamady,Shoura Karar,Ali Arshad,Adam Yarwood,Mohammed Hammoda,Maria Artigas,Sandra Paterna-López
DOI: https://doi.org/10.1016/j.hpb.2024.04.010
Abstract:Background: Diabetes mellitus (DM) has a complex relationship with pancreatic cancer. This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). Methods: Data were extracted from the Recurrence After Whipple's (RAW) study, a multi-centre cohort of PD for pancreatic head malignancy (2012-2015). Recurrence and five-year survival rates of patients with DM were compared to those without, and subgroup analysis performed to compare patients with recent-onset DM (less than one year) to patients with established DM. Results: Out of 758 patients included, 187 (24.7%) had DM, of whom, 47 of the 187 (25.1%) had recent-onset DM. There was no difference in the rate of postoperative pancreatic fistula (DM: 5.9% vs no DM 9.8%; p = 0.11), five-year survival (DM: 24.1% vs no DM: 22.9%; p = 0.77) or five-year recurrence (DM: 71.7% vs no DM: 67.4%; p = 0.32). There was also no difference between patients with recent-onset DM and patients with established DM in postoperative outcomes, recurrence, or survival. Conclusion: We found no difference in five-year recurrence and survival between diabetic patients and those without diabetes. Patients with pre-existing DM should be evaluated for PD on a comparable basis to non-diabetic patients.